Starling Oncology (STLN) Profit After Tax (QoQ) (2020 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Profit After Tax (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -292.82% |
| Mar 31, 2026 | 66.81% |
| Dec 31, 2025 | 54.51% |
| Sep 30, 2025 | 2.97% |
| Jun 30, 2025 | 13.15% |
| Mar 31, 2025 | -48.57% |
| Dec 31, 2024 | 18.19% |
| Sep 30, 2024 | -4.10% |
| Jun 30, 2024 | 22.17% |
| Mar 31, 2024 | -6.05% |
| Dec 31, 2023 | -7.66% |
| Sep 30, 2023 | -3.09% |
| Jun 30, 2023 | 43.67% |
| Mar 31, 2023 | -6.61% |
| Dec 31, 2022 | -952.32% |
| Sep 30, 2022 | 50.96% |
| Jun 30, 2022 | -128.27% |
| Mar 31, 2022 | 289.90% |
| Dec 31, 2021 | -240.81% |
| Sep 30, 2021 | -192.98% |